Pulse Biosciences (PLSE) Return on Capital Employed (2016 - 2025)

Pulse Biosciences' Return on Capital Employed history runs 10 years deep, the most recent figure standing at 75.33% for Q3 2025.

• In Q3 2025, Return on Capital Employed rose 556.0% year-over-year to 75.33%; the TTM figure through Sep 2025 stood at 75.33% (up 556.0% YoY), while the FY2025 annual figure was 68.95%, up 13456.0% from the prior year.
• Return on Capital Employed was 75.33% for Q3 2025 at Pulse Biosciences, down from 61.3% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 50.88% in Q1 2025 to a low of 187.59% in Q2 2022.
• Historically, Return on Capital Employed has averaged 92.18% across 5 years, with a median of 80.89% in 2024.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed tumbled 10244 bps in 2022, then jumped 11797 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 111.64% in 2021, then soared by 32 bps to 75.65% in 2022, then retreated by 3 bps to 78.03% in 2023, then climbed by 30 bps to 54.78% in 2024, then plunged by 38 bps to 75.33% in 2025.
• The last three Return on Capital Employed figures came in at 75.33% (Q3 2025), 61.3% (Q2 2025), and 50.88% (Q1 2025), per Business Quant data.